68 related articles for article (PubMed ID: 3164801)
1. Fatty acid composition of HL-60 cells is modified upon proliferation arrest and differentiation.
Gény B; Lagarde M; Ladoux A; Abita JP
Leukemia; 1988 Jul; 2(7):459-65. PubMed ID: 3164801
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells.
Kohlhepp EA; Condon ME; Hamburger AW
Exp Hematol; 1987 May; 15(4):414-8. PubMed ID: 3471521
[TBL] [Abstract][Full Text] [Related]
3. Changes in the patterns of protein phosphorylation associated with granulocytic and monocytic-induced differentiation of HL-60 cells.
Faille A; Poirier O; Turmel P; Chomienne C; Charron DJ; Abita JP
Anticancer Res; 1986; 6(5):1053-63. PubMed ID: 3467646
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sterol and phospholipid synthesis in HL-60 promyelocytic leukemia cells by inducers of myeloid differentiation.
Cooper RA; Ip SH; Cassileth PA; Kuo AL
Cancer Res; 1981 May; 41(5):1847-52. PubMed ID: 6938303
[TBL] [Abstract][Full Text] [Related]
5. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
6. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
7. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Frank DA; Sartorelli AC
Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
[TBL] [Abstract][Full Text] [Related]
8. Effect of docosahexaenoic acid on rate of differentiation of HL-60 human leukemia.
Burns CP; Petersen ES; North JA; Ingraham LM
Cancer Res; 1989 Jun; 49(12):3252-8. PubMed ID: 2541901
[TBL] [Abstract][Full Text] [Related]
9. Analysis of commitment of human leukemia HL-60 cells to terminal granulocytic maturation.
Tsiftsoglou AS; Wong W; Hyman R; Minden M; Robinson SH
Cancer Res; 1985 May; 45(5):2334-9. PubMed ID: 3857118
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60.
Zylber-Katz E; Glazer RI
Cancer Res; 1985 Oct; 45(10):5159-64. PubMed ID: 3161611
[TBL] [Abstract][Full Text] [Related]
11. Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: dimethyl sulfoxide inhibits IL-6-induced differentiation of SKW6-CL4 into IgM-secreting plasma cells.
Teraoka H; Mikoshiba M; Takase K; Yamamoto K; Tsukada K
Exp Cell Res; 1996 Jan; 222(1):218-24. PubMed ID: 8549666
[TBL] [Abstract][Full Text] [Related]
12. [Decrease of insulin binding to human acute leukemic cells during chemically induced differentiation].
Palumbo A; Turco GL; Brossa C; D'Alberto M; Ghezzo F; Pegoraro L
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1350-4. PubMed ID: 7004463
[TBL] [Abstract][Full Text] [Related]
13. [Changes of fibrinolytic activity of human HL60 acute leukemia cells responses to chemically induced differentiation].
Ghezzo F; Palumbo A; Pegoraro L
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1355-9. PubMed ID: 6934784
[TBL] [Abstract][Full Text] [Related]
14. Imbalance in the nucleotide pools of myeloid leukemia cells and HL-60 cells: correlation with cell-cycle phase, proliferation, differentiation, and transformation.
de Korte D; Haverkort WA; de Boer M; van Gennip AH; Roos D
Cancer Res; 1987 Apr; 47(7):1841-7. PubMed ID: 3469022
[TBL] [Abstract][Full Text] [Related]
15. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
16. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
17. Characterization of differentiation-inducer-resistant HL-60 cells.
Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
[TBL] [Abstract][Full Text] [Related]
18. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
[TBL] [Abstract][Full Text] [Related]
19. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine.
Yen A; Forbes ME
Cancer Res; 1990 Mar; 50(5):1411-20. PubMed ID: 2302706
[TBL] [Abstract][Full Text] [Related]
20. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
Paukovits JB; Paukovits WR; Laerum OD
Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
